Olema Corp - Rega Nyata Tumbas Perusahaan Kanthi Wutuh OLMA

Olema Pharmaceuticals adheres to standard environmental regulations for bio-waste disposal. This non-cyclical biotech focuses on targeted therapy, where success depends on investment rather than market phases. The market capitalization trend on the GURU.Markets platform is 197.95, confirming the potential to create unique molecules for receptor blocking, which allows the company to overcome treatment resistance and strive for a monopoly position.

OLMA Olema Pharmaceuticals, Inc.: Nilai Perusahaan ing interval 23.11.2025 - 29.10.2026

Rincian metrik keuangan lan pasar Olema Pharmaceuticals (OLMA)

- rega lan prakiraan konsensus rega:

Bagan rega Olema Pharmaceuticals, Inc.|OLMA - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Olema Pharmaceuticals|OLMA - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham Olema Pharmaceuticals|OLMA - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku olema.com|OLMA - Aset Agregat Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Olema Pharmaceuticals|OLMA - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal olema.com|OLMA - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Olema Pharmaceuticals|OLMA - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Olema Pharmaceuticals

Ringkesan analitik perusahaan:Olema Pharmaceuticals, Inc. (OLMA)

Investors must evaluate business resilience through the lens of actual asset acquisition costs. For Olema Pharmaceuticals (OLMA) and its development of paleserant, such a cost reflects the market price of oncology prospects. Analyzing the enterprise value as of the current date, we see the sum of market capitalization and net debt. This metric eliminates liquidity distortions, demonstrating the actual purchase price of the business. Minimizing this indicator while maintaining therapeutic potential reduces the risk of overpayment.

Perusahaan pesaing